HELX Franklin Genomic Advancements ETF
Holds 61 stocks in healthcare innovation and GLP-1, 15% of its weight in S&P 500 companies
HELX holds 61 stocks, and 85% of its weight is outside the S&P 500.
Key facts
ETFIQ Off-Index Score
41.4joint 216th of 371
HELX shares 11 of its 61 holdings with the S&P 500. Only 2.8% of its weight overlaps the index.
How much of it is not the index it is sold as an alternative to?
That is the share of the 371 thematic ETFs with a holdings filing sitting at or below HELX. A position in this set, not a rating: it moves when the set moves, and it is not a figure to average against another desk's.
2nd of 8 healthcare innovation and glp-1 ETFs by net assets 1st of 8 healthcare innovation and glp-1 ETFs by least weight in the S&P 500
Its ten largest equity positions
| Holding | Ticker | Weight | |
|---|---|---|---|
| GUARDANT HEALTH INC | GH | 9.21% | |
| NATERA INC | NTRA | 7.56% | |
| KRYSTAL BIOTECH INC | KRYS | 6.41% | |
| LIGAND PHARMACEUTICALS INC | LGND | 4.68% | |
| ADAPTIVE BIOTECHNOLOGIES CORP | ADPT | 4.04% | |
| UNITED THERAPEUTICS CORP | UTHR | 3.55% | |
| BRIDGEBIO PHARMA INC | BBIO | 3.54% | |
| ELI LILLY & COMPANY | LLY | 2.99% | |
| TWIST BIOSCIENCE CORP | TWST | 2.89% | |
| VERTEX PHARMACEUTICALS INC | VRTX | 2.78% |
Period by period
| Window | Total return | S&P 500 | Gap to S&P 500 | Gap to Nasdaq-100 |
|---|---|---|---|---|
| 3 months | +15.6% | +3.3% | +12.3 pts | +16.4 pts |
| 6 months | +28.1% | +16.0% | +12.1 pts | +7.5 pts |
| 1 year | +33.6% | +17.5% | +16.1 pts | +10.7 pts |
| 3 years | +38.7% | +77.9% | −39.2 pts | −56.4 pts |
| Since launch | +72.4% | +182.0% | −109.6 pts | −189.2 pts |
In plain words
The top ten holdings are 48% of the fund across 61 positions, as filed for Jun 30, 2026. Over the year to Sep 11, 2026 the fund returned +33.6% with distributions reinvested against +17.5% for the S&P 500, so a holder was ahead by 16.1 pts. It sits 29.2% below its all-time high of Sep 7, 2021.
| Theme (ETFIQ, editorial) | Healthcare innovation and GLP-1 |
|---|---|
| Launched | Feb 27, 2020 |
| Already in the S&P 500, by weight (ETFIQ) | 15.1% |
| Active share vs the S&P 500 (ETFIQ) | 97.2% |
| Already in the Nasdaq-100, by weight (ETFIQ) | 10.0% |
| Active share vs the Nasdaq-100 (ETFIQ) | 98.5% |
| Top ten holdings weight | 47.7% |
| Holdings | 61 |
| Holdings as of (SEC N-PORT) | Jun 30, 2026 |
| Top holdings | GUARDANT HEALTH INC 9.2%, NATERA INC 7.6%, KRYSTAL BIOTECH INC 6.4%, LIGAND PHARMACEUTICALS INC 4.7%, ADAPTIVE BIOTECHNOLOGIES CORP 4.0%, UNITED THERAPEUTICS CORP 3.5%, BRIDGEBIO PHARMA INC 3.5%, ELI LILLY & COMPANY 3.0%, TWIST BIOSCIENCE CORP 2.9%, VERTEX PHARMACEUTICALS INC 2.8% |
| Net assets (issuer page, as of Sep 11, 2026) | $31m |
| Below its all-time high (ETFIQ) | −29.2% |
| Expense ratio (485BPOS XBRL, Jul 27, 2026) | 0.50% |
| Fee for the part that differs from the S&P 500, active expense ratio (ETFIQ) | 0.51% |
| Closest funds by holdings overlap | WDNA 34%, GNOM 29%, HTEC 28%, IBBQ 26%, BBH 25% |
Holdings from the fund’s latest public SEC N-PORT filing; overlap and active share computed by ETFIQ against the IVV and QQQM books; returns from Tiingo end-of-day prices with distributions reinvested. How these figures are computed
Questions people ask
- How much of HELX is in S&P 500 companies?
- By its holdings filed for Jun 30, 2026, 15% of HELX by weight is stocks the S&P 500 already holds. Its active share against the index is 97%, so that share is the part doing something different.
- What does HELX hold?
- 61 positions as filed for Jun 30, 2026, with the top ten at 48% of the fund. The largest are GUARDANT HEALTH INC at 9.2%, NATERA INC at 7.6%, KRYSTAL BIOTECH INC at 6.4%.
- Has HELX beaten the S&P 500?
- Over the year to Sep 11, 2026 HELX returned +33.6% with distributions reinvested, against +17.5% for the S&P 500, so it finished ahead of the index by 16.1 points.
- What does HELX cost?
- The prospectus expense ratio is 0.50% a year. Because 97% of the fund differs from the S&P 500, the fee on that differing part works out at 0.51%.
The words on this page
- Active share
- The part of the fund doing something the index is not, as a percentage. It is the part a fee is actually buying.
- Weight overlap
- The share of money two portfolios hold in the same securities at the same weight. Above 50%, holding both is close to holding one of them twice.
- Already in the index
- The fund’s weight in securities the S&P 500 holds at all. A fund can be made entirely of index names and still have high active share, because it holds them at very different weights.
- Top ten
- What the ten largest positions add up to. The higher it is, the more the fund is a bet on a few companies rather than a theme.
Every term used here, defined in full on the thematic ETFs vocabulary page.
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Funds near this one
Put this on your own page
The difference bar for HELX, redrawn every trading night. Free to use with the credit link.
Where HELX is written about
Use this data, or open the live card
Open HELX live on ETFIQ, where the figures refresh with the data.
Cite this page. ETFIQ, HELX, thematic ETFs, data as of Sep 11, 2026. https://etfiq.com/funds/helx Free to use with attribution; the underlying files are at Open data.